Developing Biomarkers to Classify, Detect, & Monitor Cancer
Because the clinical behavior of cancer cannot be completely accounted for using morphology alone, it is important to develop molecular techniques for diagnosis, prognosis, and guiding treatment. The Bernard Lab is a “translational” research lab committed to the discovery and clinical implementation of biomarkers for classification, detection, and monitoring of cancer in humans.
The Bernard Lab at Huntsman Cancer Institute is developing new strategies for the classification, detection, and treatment of cancer. The Bernard Lab uses high-throughput molecular methods to comprehensively profile cancers and classify tumors based on biology and clinical correlations.